The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/16562
StudyName: Eligibility Leukemia NCT00027560
Date of export from the portal: 02.07.2020
Date of Upload / last change: 24.07.2016
License: Creative Commons BY 4.0

----

Description: 
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00027560
